Provided by Tiger Trade Technology Pte. Ltd.

Astria Therapeutics Inc

12.58
0.0000
Volume:- -
Turnover:40.15M
Market Cap:718.13M
PE:-5.88
High:12.58
Open:12.58
Low:12.58
Close:12.58
52wk High:13.29
52wk Low:3.56
Shares:57.08M
Float Shares:38.38M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1381
EPS(LYR):-1.6784
ROE:-43.15%
ROA:-26.94%
PB:2.47
PE(LYR):-7.50

Loading ...

One new option listing and one option delisting on January 26th

TIPRANKS
·
Jan 26

BioCryst Completes Acquisition of Astria Therapeutics

Reuters
·
Jan 26

BioCryst Pharmaceuticals Amends Board Appointment Disclosure

Reuters
·
Jan 24

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Reuters
·
Jan 23

Astria Therapeutics Shareholders Greenlight Acquisition by BioCryst Pharmaceuticals

MT Newswires Live
·
Jan 22

BRIEF-Astria Stockholders Vote To Approve Acquisition By Biocryst

Reuters
·
Jan 22

Astria Shareholders Approve Acquisition by BioCryst

Reuters
·
Jan 22

Astria Stockholders Vote to Approve Acquisition by BioCryst

THOMSON REUTERS
·
Jan 22

BioCryst Projects 2026 ORLADEYO Revenue of $625 Million to $645 Million

Reuters
·
Jan 12

BRIEF-Astria Therapeutics Inc - Complaints Filed Against Astria In New York Supreme Court - SEC Filing

Reuters
·
Dec 24, 2025

Astria Therapeutics Inc: Believes That Claims Asserted in Complaints Are Without Merit

THOMSON REUTERS
·
Dec 24, 2025

Astria Therapeutics - Complaints Allege Negligence & Negligent Misrepresentation & Concealment Against Astria & Board- SEC Filing

THOMSON REUTERS
·
Dec 24, 2025

Astria Therapeutics to Be Acquired by BioCryst Pharmaceuticals

Reuters
·
Dec 24, 2025

Vincent J. Milano Named Next Chair of BioCryst Pharmaceuticals Board

Reuters
·
Dec 11, 2025

BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition

Reuters
·
Dec 03, 2025

Astria Therapeutics Inc - Net Loss per Share $0.55 for Q3 2025

THOMSON REUTERS
·
Nov 12, 2025

BioCryst to Acquire Astria Therapeutics for $8.55 Per Share and Stock

Reuters
·
Nov 12, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

Astria Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Astria Therapeutics' Final Phase 1b/2 Trial Results For Hereditary Angioedema Treatment Show Strong Efficacy

MT Newswires Live
·
Nov 07, 2025